INCLINE VILLAGE, Nev., Oct. 30, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) today announced that it will release its third quarter 2019 financial results for the period ended September 30, 2019, on Wednesday, November 6, 2019, after market close.  PDL's management will host a conference call and webcast that day at 4:30 p.m. Eastern time to discuss the operating and financial results and recent developments.  A slide presentation relating to the call will be available via the webcast link on the PDL website at http://www.pdl.com/.

Conference Call Details
To access the live conference call via phone, please dial (844) 535-4071 from the United States and Canada or (706) 679-2458 internationally.  The conference ID is 3195828.  Please dial in approximately 10 minutes prior to the start of the call.  A telephone replay will be available for one week following the call and may be accessed by dialing (855) 859-2056 from the United States and Canada or (404) 537-3406 internationally.  The replay passcode is 3195828.

To access the live and subsequently archived webcast of the conference call, go to the Company's website and go to "Events & Presentations."  Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary.

About PDL BioPharma
PDL's mission is to improve the lives of patients and create value for our shareholders and our people by applying our capital and expertise for the successful development and commercialization of innovative therapeutics by our partner companies.  We deliver on our mission by entering into strategic transactions involving innovative late clinical-stage or early commercial-stage therapeutics with attractive revenue growth potential.  For more information please visit www.pdl.com.

NOTE:  PDL, PDL BioPharma, the PDL logo and associated logos and the PDL BioPharma logo are trademarks or registered trademarks of, and are proprietary to, PDL BioPharma, Inc. which reserves all rights therein.

PDL BioPharma, Inc. (PRNewsFoto/PDL BioPharma, Inc.)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-to-announce-third-quarter-2019-financial-results-on-november-6-2019-300945219.html

SOURCE PDL BioPharma, Inc.

Copyright 2019 PR Newswire

PDL BioPharma (NASDAQ:PDLI)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more PDL BioPharma Charts.
PDL BioPharma (NASDAQ:PDLI)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more PDL BioPharma Charts.